Keywords: ec, approves, bayer, nexavar, rcc, german, drugmaker

EC approves Bayer's Nexavar for RCC

Article | 31 July 2006

Print This

German drugmaker Bayer AG says that the European Commission has granted marketing authorization for its oral drug Nexavar (sorafenib) for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in